FDA OKs Diabetes Drug for Type 2 Heart Failure Risk

The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.

from WebMD Health https://ift.tt/2Jcu9tn